| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Recent advancements in genetic therapies and the introduction of new weight-loss medications highlight a promising trajectory for innovation and growth in the market. Eli Lilly's partnership to offer Zepbound reflects a strategic response to increasing consumer demand for effective health solutions. These developments signal enhanced opportunities for market expansion and the potential to address significant health challenges. However, the competitive landscape and regulatory hurdles can pose risks to the successful implementation of these new products. |
| The price action of Eli Lilly (LLY) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at -0.3 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for LLY since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0, and the negative at -0.3 on 2025-04-04. The forces of Valuation Sentiment (-1), and Sentiment towards Fundamentals (-0.7) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), and Market Risk Appetite (0) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| LLY | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-04 | 0%(0%) | 0 | 0% | -0.3 | -0.7 | -1 | |||||||
| 2025-04-03 | 0%(0%) | 0 | 0% | -0.2 | -0.3 | -1 | |||||||
| 2025-04-02 | 0%(0%) | 0 | 0% | -0.1 | 0.4 | -1 | |||||||
| 2025-04-01 | 0%(0%) | 0 | 0% | -0 | 0.9 | -1 | |||||||
| 2025-03-31 | 0%(0%) | 0 | 0% | 0.1 | 1.4 | -1 | |||||||
| 2025-03-28 | 0%(0%) | 0 | 0% | 0.1 | 1.7 | -1 | |||||||
| 2025-03-27 | 0%(0%) | 0 | 0% | 0.2 | 1.9 | -1 | |||||||
| 2025-03-26 | 0%(0%) | 0 | 0% | 0.3 | 2.5 | -1 | |||||||
| 2025-03-25 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| 2025-03-24 | 0%(0%) | 0 | 0% | 0.5 | 3.7 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-05-19 17:08:56 Companies are navigating a competitive landscape through strategic partnerships and advancements in their product offerings, particularly in the biotech sector. |
| 2025-05-19 17:08:56 The licensing deal between Sangamo Therapeutics and Eli Lilly points to emerging opportunities in genomic medicine and potential significant financial returns. |
| 2025-05-19 17:08:56 The decline in stocks of Eli Lilly and Novo highlights how healthcare policy changes can lead to significant market volatility in the pharmaceutical sector. |
| 2025-05-19 17:08:56 The withdrawal of a Biden administration proposal to cover obesity drugs under Medicare reflects shifting political priorities affecting healthcare access. |
| 2025-05-19 17:08:56 Recent changes in Medicare policies negatively affect the coverage of weight-loss drugs, which has implications for patients and pharmaceutical companies. |